Articles tagged with Cell Apoptosis
Researchers studied Zika virus's effects on animal models during early postnatal development and at weaning, finding increased apoptosis in certain brain areas and cell types. This knowledge could help develop treatments for Zika-related birth defects such as microcephaly.
Researchers mapped the first active human apoptosome, a wheel-like structure that recruits proteases to dismantle proteins and induce cell death. The study provides insights into how this process is regulated and may lead to treatment options for cancer, AIDS, and neurodegenerative diseases.
Researchers found that platelets must undergo a process called mitochondrial necrosis, where they release calcium and reactive oxygen species, causing the cell to collapse. This programmed death allows platelets to transition into super-activated states, which accelerate blood clotting.
A team of researchers from TUM has identified a molecular signaling pathway for programmed cell death that is suppressed in leukemia cells. This discovery offers new insights into the mechanisms underlying cancer progression and may lead to targeted treatment options.
Research highlights the intertwined pathways regulating apoptosis and cellular senescence in cancer and aging. The review suggests that harnessing benefits of both processes could lead to new combination therapies, while limiting drawbacks.
Researchers at MUSC discovered that Dab2 is a molecular switch regulating autophagy or apoptosis in tumor cells. Maintaining Dab2 levels blocks autophagy and promotes cell death, enhancing chemotherapeutic agent efficacy. In vivo studies showed Dab2 reduces tumor metastasis and increases drug-induced cell death.
A new diagnostic tool uses short-strand DNA library preparation to analyze cell-free DNA in plasma, enabling transplant recipients to get an idea of how their new organ is responding via a simple blood test. This method can help determine whether the transplanted organ is injured or being rejected.
Georgia State researchers discover a new class of protein, ProAgio, that effectively targets the cell surface receptor integrin v3, linked to various diseases including cancer. ProAgio induces apoptosis, killing pathological cells and preventing tumor growth, with minimal toxicity to normal tissue.
A novel cellular membrane protein called TSPAN2 has been identified as a key player in beta-cell apoptosis. The study suggests that targeting TSPAN2 could become a new treatment strategy for type 2 diabetes.
Protein ProAgio induces apoptosis in cells expressing integrin αVβ3, a receptor linked to various diseases. The study found ProAgio strongly inhibits tumor growth and prevents blood vessel formation.
Melbourne researchers have discovered a novel way of directly activating Bak, a protein central to apoptosis, to trigger cell death. This finding holds promise for developing drugs that promote cell death in cancer and autoimmune diseases.
Researchers discovered a new way to kill rapidly multiplying cancer cells using necroptosis, an alternative form of cell death. This approach may lead to more effective treatments for patients with acute myeloid leukaemia (AML) who have resisted traditional therapies.
Researchers have discovered that the activation of endogenous retroviral genes in B cells can lead to programmed cell death and disrupt immune system development. This occurs when the silencing mechanism fails, allowing viral proteins to accumulate and trigger an unfolded protein response, ultimately leading to apoptosis.
A study reveals CHOP/GADD153-dependent apoptosis is driven by micro-RNA miR-216b expression in response to endoplasmic reticulum stress, with significant implications for various diseases. The findings provide molecular insights into the role of CHOP in regulating cell death and have potential applications for novel therapies.
Vishva Dixit's research on programmed cell death has significantly contributed to the understanding of apoptosis mechanisms, with implications for cancer treatment and neurodegenerative diseases. His work also revealed the association between inflammatory diseases and the immune system, shedding light on novel therapeutic strategies.
The Gutenberg Research College has appointed Professor Klaus Müllen as a new fellow, while presenting Dr. Vishva Dixit with the Gutenberg Research Award 2016 for his groundbreaking research in apoptosis and inflammation.
Scientists at Rockefeller University have identified a new way for cells to die in the linker cell of Caenorhabditis elegans, resembling neuronal death in humans. The discovery suggests that this process might be involved in neurodegenerative disorders and could serve as a target for future drugs.
Researchers have discovered a new drug, HRX9, that targets the HOX gene family and induces apoptosis in mesothelioma cells. The study found that treatment with HRX9 resulted in complete loss of tumor blood vessels and widespread cancer cell death, offering new hope for patients.
Researchers discovered a common molecular alteration in glioblastoma that prevents cells from degrading genetic material during apoptosis. This defect is related to an enzyme called endonuclease DFF40/CAD, which is downregulated and improperly located inside tumour cells.
Scientists have observed ring-shaped pores in the Bax protein, which perforates mitochondrial membranes and initiates cell death. This discovery may lead to a better understanding of apoptosis and its role in preventing cancer.
Researchers have identified a key mechanism in regulating cell survival by controlling mRNA stability, shedding light on programmed cell death mechanisms. The study suggests that the CCR4-NOT complex plays a vital role in maintaining cellular integrity and that its component protein CNOT3 is crucial for cell viability.
Researchers identified VRAC channels as responsible for half of anti-cancer drug uptake, with down-regulated subunits linked to therapy resistance and programmed cell death disturbances. The study's findings hold high clinical relevance and suggest potential new targets for overcoming cancer therapy resistance.
The IKK complex plays an unexpected role in protecting cells from death by inactivating RIPK1. This discovery reveals a new mechanism of action for the IKK complex beyond its well-known NF-kB-dependent functions, providing potential therapeutic targets for inflammatory conditions.
A study by Helmholtz Munich researchers identified a key role of the protein BMP7 in promoting cell division and migration in pheochromocytoma cells. Targeting this signaling pathway with specific substances may lead to an increase in apoptosis, providing a new approach for treatment.
Researchers have discovered a new pathway that tumor suppressor protein p53 uses to induce apoptosis and kill cancer cells. The process involves a shape change in one of p53's amino acids, which activates the BAX protein and triggers cell death.
A Dartmouth team has successfully synthesized molecules that induce rapid apoptosis in leukemia cells, paving the way for further study of their biological mechanism of action. The findings hold promise for developing novel therapeutic strategies against cancer and other diseases linked to abnormal cell death.
A team of researchers has identified netrin-1 as a molecule that can favour the production of induced pluripotent stem cells, which have huge potential applications in regenerative medicine. The discovery may ultimately enable the creation of new organs from patient cells, eliminating rejection risks and ethical concerns.
Researchers identified a cellular signal causing kidney cells to die, leading to increased risk of acute kidney injuries. The study found that lack of alpha(E)-catenin protein contributes to this process.
Researchers at UC Davis and the University of Delaware discovered that chloroplast tubes play a key role in plants' immune defense. The discovery reveals how chloroplasts deliver signals to the nucleus, inducing programmed cell death and preparing other cells to resist infection.
Researchers at the Center for Genomic Regulation have identified a new mechanism that generates forces to drive cell movements during development, replacing previous theories of shape changes. This discovery contributes to understanding organ development and maintenance by highlighting the role of volume changes and programmed cell death.
Dying daughter cells release protein Pvf1, binding to nearby mother stem cells' receptors, preventing apoptosis. This allows stem cells to survive until they can regenerate damaged tissue. The discovery may lead to new cancer treatments by targeting protective signals in tumor-initiating cells.
A team of researchers from Plymouth University is studying a protein called Bim, which causes cell death in the brain and regulates autophagy and apoptosis. They aim to understand how Bim levels increase in Huntington's disease and test the effectiveness of a Bim-derived peptide in treating the disease.
Scientists use advanced omics technologies to analyze the effects of substances on human cells, revealing potential health risks at very low concentrations. The study identifies changes in protein patterns and metabolism at non-toxic levels, which could inform the development of new risk assessment methods.
Researchers have discovered a novel mechanism of neuronal death involved in neurodegenerative protein-misfolding diseases like Alzheimer's and Parkinson's. The study found that the loss of NAD+ is the primary cause of neuronal demise, and restoring it can rescue neurons.
Two studies found a unique molecule that can repair damaged nerve cells by locating and clearing out bad cells. The phosphatidylserine receptor (PSR-1) also helps reconnect broken nerve fibers in the regeneration process.
Researchers found a mutated region in human mantle cell lymphoma DNA that disables programmed cell death. Cells with this mutation grow uncontrollably, but a new therapy approach targets the ubiquitin ligase responsible for the defect.
New research solves decades-old mystery of silent cell death, revealing how dying cells hide from the immune system. The study identified the role of caspases in suppressing interferon release, providing insights into links between cell death, the immune system and disease.
Researchers demonstrate that the innate immune system recognizes weaker cells and activates programmed cell death, eliminating them in a process called cell competition. This phenomenon has implications for cancer research and early disease detection.
Researchers at the Walter and Eliza Hall Institute discovered that inflammatory skin diseases such as psoriasis are linked to abnormal apoptosis, while necroptosis is associated with systemic inflammation. This finding could lead to the development of new treatments for these conditions.
Krishnaraj Rajalingam, a leading molecular cell biologist, has been awarded the Gutenberg Research College fellowship to establish a research team at Mainz University. His research focuses on understanding cellular signaling pathways to develop novel therapeutics for major human diseases like cancer.
Melbourne researchers have discovered the three-dimensional structure of a key cell death protein called Bak and revealed how it causes cell death. The study offers new targets for treating diseases such as lupus, cancers, and neurodegenerative disorders.
Researchers at UTMB have discovered three small-molecule compounds that activate Bax and induce high levels of cell death in lung cancer cells without harming noncancerous tissues. These findings represent a new class of anticancer drugs with a unique therapeutic target for the treatment of cancers expressing Bax, including lung cancer.
Casp8 activity arose over 500 million years ago and is universally conserved throughout evolution. Key protein interactions between Casp8 and FADD are also observed across the animal kingdom, suggesting a vital cell death toolkit in animal evolution.
Researchers successfully constructed an adenovirus that induces DHCR24 specifically in neuronal cells, demonstrating its neuroprotective effects against amyloid beta-induced apoptosis. This breakthrough paves the way for further studies on DHCR24 gene therapy and neuronal functional research.
A recent study found that TAG-1 induces apoptosis-related gene expression in U251 glioma cells, but surprisingly, this pathway does not trigger apoptosis. Instead, it enhances cell proliferation. The study provides novel insights into the mechanisms of glial tumorigenesis.
Research found that cholecystokinin octapeptide-8 (CCK-8) protects human retinal pigment epithelial cells by suppressing apoptosis triggered by peroxynitrite. The study suggests a potential therapeutic role for CCK-8 in treating age-related macular degeneration.
Researchers found that Yizhijiannao granule inhibits neuronal apoptosis, reducing tau phosphorylation and neuroinflammation in Alzheimer's disease. The study identified multiple proteins involved in regulating amyloid beta production, oxidative stress, and neuronal survival.
Researchers have created a synthetic ion transporter that can cause cancer cells to self-destruct by disrupting the delicate balance of ions within their cell membranes. The molecule, which was discovered after two decades of research, confirms a hypothesis that could lead to new anticancer drugs and benefit patients with cystic fibrosis.
The study found that high doses of Notch-1 signaling pathway inhibitor prolonged the survival of PC12 cells after Aβ25-35 induction, decreasing apoptosis-related proteins and increasing antioxidant enzyme activity. The results suggest a protective effect against amyloid beta-peptide-induced cell death.
Researchers at the Affiliated Hospital of Qingdao University discovered that mitochondrial proteins are associated with energy metabolism and apoptosis in aged rats. The study found potential targets for treating transient cerebral ischemia-reperfusion injury, providing a new avenue for treating stroke in the elderly.
A novel HIF-1α viral vector effectively reduces apoptosis in primary cultured hippocampal neurons exposed to amyloid-beta protein. This breakthrough may lead to the development of gene therapy as a potential clinical treatment for Alzheimer's disease.
Researchers found that adipose-derived stromal cells exhibit increased apoptotic rates and decreased viability when attempting to differentiate into astrocytes. This process is hindered by caspase-dependent apoptosis, a crucial strategy for increasing induction efficiency.
Inhibition of NgR expression reduces apoptosis of retinal ganglion cells in diabetic rats by inhibiting Rho kinase, indicating a potential therapeutic target for glaucoma and related diseases. Upregulation of NgR is associated with increased cell apoptosis and visual extinction.
Researchers found that non-invasive brain stimulations, including rTMS and tDCS, can regulate the activities of cerebral motor cortex neurons. These findings suggest potential therapeutic benefits for individuals with central nervous system injuries or damage.
The study found that electrical stimulation of the fastigial nucleus can increase Ku70 expression, leading to decreased Bax protein and reduced mitochondrial apoptosis. Injured brain tissue showed co-localization of Ku70 with Bax.
A new study reveals that humans and corals have a shared biomechanical pathway responsible for triggering cellular self-destruction. This finding has important implications for understanding the early evolution of multicellular life, conservation of corals, and development of new drugs to fight diseases like cancer.
Researchers have identified a protein that regulates calcium levels in cells, which could be a promising strategy for fighting cancers. The study reveals how this protein serves as a molecular safety valve to maintain steady calcium levels.
Researchers discovered that RIPK1 acts as an umpire to make tough life-or-death calls in cells. By removing different components of two pathways, the study showed that RIPK1 helps maintain a balanced response to signals promoting either pathway. This finding resolves long-standing questions about RIPK1's role in cell survival and provi...
Detailed studies at St. Jude Children's Research Hospital reveal the structural details of how p53 attaches to its regulatory protein BCL-xL, enabling scientists to design drugs that release p53 in cancer cells, triggering apoptosis. The findings have significant implications for developing new cancer-fighting treatments.
Researchers successfully constructed an adenovirus that induces DHCR24 specifically in neuronal cells, leading to reduced apoptosis. The findings suggest potential for future studies on DHCR24 gene therapy and neuronal functional research.